Characteristics
|
Univariate analysis
|
Multivariate analysis
|
---|
HR
|
95%CI
|
P value
|
HR
|
95%CI
|
P value
|
---|
Age
| | |
0.023
| | |
0.013
|
≤ 57
|
1.000
|
Reference
| |
1.000
|
Reference
| |
>57
|
1.458
|
1.053–2.020
| |
1.524
|
1.091–2.129
| |
Gender
| | |
0.139
| | | |
Male
|
1.000
|
Reference
| | | | |
Female
|
0.777
|
0.556–1.086
| | | | |
Smoking history
| | |
0.120
| | | |
Y
|
1.000
|
Reference
| | | | |
N
|
0.775
|
0.563–1.068
| | | | |
Stage
| | |
<0.001
| | |
0.051
|
I-II
|
1.000
|
Reference
| |
1.000
|
Reference
| |
IIIA
|
3.075
|
2.279–4.148
| |
1.747
|
0.997–3.060
| |
Pathological tumor
| | | | | | |
Classification (pT)
| | |
0.009
| | |
0.285
|
pT1–2
|
1.000
|
Reference
| |
1.000
|
Reference
| |
pT3–4
|
1.663
|
1.138–2.430
| |
1.295
|
0.806–2.078
| |
Pathological lymph node
| | | | | | |
stage (pN)
| | |
<0.001
| | |
<0.001
|
pN0
|
1.000
|
Reference
| |
1.000
|
Reference
| |
pN1–2
|
3.842
|
2.772–5.323
| |
4.574
|
2.694–7.767
| |
Histological type
| | |
0.136
| | | |
Squamous cell carcinoma
|
1.000
|
Reference
| | | | |
Adenocarcinoma
|
0.847
|
0.611–1.173
| | | | |
Large cell carcinoma
|
1.371
|
0.815–2.305
| | | | |
Surgery type
| | |
<0.001
| | |
0.613
|
Lobectomy
|
1.000
|
Reference
| |
1.000
|
Reference
| |
Pneumonectomy
|
2.379
|
1.719–3.293
| |
1.250
|
0.760–2.056
| |
Other
|
2.231
|
1.316–3.781
| |
1.026
|
0.543–1.938
| |
Adjuvant chemotherapy
| | |
<0.001
| | |
0.002
|
Y
|
1.000
|
Reference
| |
1.000
|
Reference
| |
N
|
2.190
|
1.596–3.006
| |
2.607
|
1.439–4.723
| |
GLU (mmol/L)
| | |
0.115
| | | |
≤ 5.75
|
1.000
|
Reference
| | | | |
>5.75
|
0.761
|
0.542–1.068
| | | | |
TC (mmol/L)
| | |
0.490
| | | |
≤ 4.59
|
1.000
|
Reference
| | | | |
>4.59
|
0.896
|
0.655–1.225
| | | | |
TG (mmol/L)
| | |
<0.001
| | |
<0.001
|
≤ 1.21
|
1.000
|
Reference
| |
1.000
|
Reference
| |
>1.21
|
2.217
|
1.640–2.997
| |
1.891
|
1.385–2.583
| |
HDL-C (mmol/L)
| | |
<0.001
| | |
<0.001
|
≤ 1.26
|
1.000
|
Reference
| |
1.000
|
Reference
| |
>1.26
|
0.371
|
0.260–0.527
| |
0.430
|
0.301–0.613
| |
LDL-C (mmol/L)
| | |
0.046
| | |
0.742
|
≤ 2.26
|
1.000
|
Reference
| |
1.000
|
Reference
| |
>2.26
|
1.399
|
1.006–1.945
| |
1.059
|
0.752–1.492
| |
ApoA1(g/L)
| | |
0.181
| | | |
≤ 1.21
|
1.000
|
Reference
| | | | |
>1.21
|
0.811
|
0.597–1.102
| | | | |
ApoB(g/L)
| | |
0.222
| | | |
≤ 1.15
|
1.000
|
Reference
| | | | |
>1.15
|
0.726
|
0.434–1.214
| | | | |
Lpa (mg/L)
| | |
0.374
| | | |
≤ 53
|
1.000
|
Reference
| | | | |
>53
|
0.828
|
0.546–1.256
| | | | |
- Data were analyzed by Cox proportional hazards model. P < 0.05 was considered significant